Helus Pharma Inc.
For the period ended Mar 31, 2024. Filed Jun 26, 2024.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Jun 26, 2024
Use the contents to explore the available documents and sections.
HELP$8.96+6.8%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · Page 53 of
CYBIN INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS March 31, 2024 and 2023(All amounts expressed in thousands of Canadian dollars, except share and per share amounts, and those amounts indicated as being in US dollars, Euros and Great Britain Pounds which are in thousands.)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.